Figure 4.Riluzole potential action in AD. By directly targeting the WNT pathway, Riluzol could act on neuroinflammation, oxidative stress and the glutamatergic pathway involved in AD process.
Figure 4 — Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway | Aging
